オルガノイドの世界市場2020-2030：種類別（胃、腸、肝臓、膵臓、肺、脳、腎臓、その他）、用途別、原料別

• 英文タイトル：Organoids Market (Type: Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others; Application: Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery & Personalized Medicine, and Others; and Source: Pluripotent Stem Cells [hIPSCs] and Organ-speci?c Adult Stem Cells [ASCs]) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

• レポートコード：MRC20A58 • 出版社/出版日：Transparency Market Research / 2020年11月30日 • レポート形態：英文、PDF、190ページ • 納品方法：Eメール • 産業分類：製薬

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートは、オルガノイドの世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（胃、腸、肝臓、膵臓、肺、その他）分析、用途別分析、原料別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況などを掲載しています。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・オルガノイドの世界市場規模：種類別（胃、腸、肝臓、膵臓、肺、その他） ・オルガノイドの世界市場規模：用途別 ・オルガノイドの世界市場規模：原料別 ・オルガノイドの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ） ・競争状況

Organoids Market – Scope of the Report

TMR’s report on the global organoids market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global organoids market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global organoids market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global organoids market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global organoids market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on changing competitive dynamics in the global organoids market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global organoids market. The next section of the global organoids market report highlights the USPs, which include increase in incidence & prevalence of diseases, including infectious and other chronic disease, adoption of organoids in the research & development, technological advancements, and COVID-19 pandemic impact on the global organoids market.

The report delves into the competition landscape of the global organoids market. Key players operating in the global organoids market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global organoids market report.

Key Questions Answered in Organoids Market Report

What is the sales/revenue generated by the global organoids market across all regions during the forecast period?
What are the key trends in the global organoids market?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2030, and which type, application, and source segment will expand at the fastest CAGR during the forecast period?
Organoids Market – Research Objectives and Research Approach

The comprehensive report on the global organoids market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global organoids market. It is followed by market introduction, market dynamics, and an overview of the global organoids market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global organoids market. The next section of the global organoids market report highlights the USPs, which includes increase in incidence and prevalence of diseases, including infectious and other chronic conditions, adoption of organoids in the research & development, technological advancements, and COVID-19 pandemic impact on the global organoids market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global organoids market in terms of value. The forecast presented here assesses the total revenue generated in the global organoids market. In order to provide an accurate forecast, we initiated by sizing up the current organoids market with the help of the parent market.

The report analyzes the global organoids market in terms of type, application, source, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global organoids market.

レポート目次

---

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Organoids Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Organoids Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Regulatory Scenario by Region/globally

5.2. Disease Prevalence & Incidence Rate globally with key countries

5.3. Technological Advancements

5.4. COVID-19 Pandemic Impact on Global Organoids Market

6. Global Organoids Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Organoids Market Value Forecast, by Type,2018–2030

6.3.1. Stomach

6.3.2. Intestine

6.3.3. Liver

6.3.4. Pancreas

6.3.5. Lung

6.3.6. Brain

6.3.7. Kidney

6.3.8. Others

6.4. Market Attractiveness Analysis, by Type

7. Global Organoids Market Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Organoids Market Value Forecast, by Application, 2018–2030

7.3.1. Developmental Biology

7.3.2. Disease Pathology of Infectious Disease

7.3.3. Regenerative Medicine

7.3.4. Drug Toxicity & Efficacy Testing

7.3.5. Drug Discovery & Personalized Medicine

7.3.6. Others

7.4. Global Organoids Market Attractiveness Analysis, by Application

8. Global Organoids Market Analysis and Forecast, by Source

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Organoids Market Value Forecast, by Source, 2018–2030

8.3.1. Pluripotent Stem Cells (hIPSCs)

8.3.2. Organ-speci?c Adult Stem Cells (ASCs)

8.4. Global Organoids Market Attractiveness Analysis, by Source

9. Global Organoids Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Organoids Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Organoids Market Attractiveness Analysis, by Region

10. North America Organoids Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Organoids Market Value Forecast, by Type,2018–2030

10.2.1. Stomach

10.2.2. Intestine

10.2.3. Liver

10.2.4. Pancreas

10.2.5. Lung

10.2.6. Brain

10.2.7. Kidney

10.2.8. Others

10.3. North America Organoids Market Value Forecast, by Application, 2018–2030

10.3.1. Developmental Biology

10.3.2. Disease Pathology of Infectious Disease

10.3.3. Regenerative Medicine

10.3.4. Drug Toxicity & Efficacy Testing

10.3.5. Drug Discovery & Personalized Medicine

10.3.6. Others

10.4. North America Organoids Market Value Forecast, by Source, 2018–2030

10.4.1. Pluripotent Stem Cells (hIPSCs)

10.4.2. Organ-speci?c Adult Stem Cells (ASCs)

10.5. North America Organoids Market Value Forecast, by Country, 2018–2030

10.5.1. U.S.

10.5.2. Canada

10.6. North America Organoids Market Attractiveness Analysis

10.6.1. By Type

10.6.2. By Application

10.6.3. By Source

10.6.4. By Country

11. Europe Organoids Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Europe Organoids Market Value Forecast, by Type,2018–2030

11.2.1. Stomach

11.2.2. Intestine

11.2.3. Liver

11.2.4. Pancreas

11.2.5. Lung

11.2.6. Brain

11.2.7. Kidney

11.2.8. Others

11.3. Europe Organoids Market Value Forecast, by Application, 2018–2030

11.3.1. Developmental Biology

11.3.2. Disease Pathology of Infectious Disease

11.3.3. Regenerative Medicine

11.3.4. Drug Toxicity & Efficacy Testing

11.3.5. Drug Discovery & Personalized Medicine

11.3.6. Others

11.4. Europe Organoids Market Value Forecast, by Source, 2018–2030

11.4.1. Pluripotent Stem Cells (hIPSCs)

11.4.2. Organ-speci?c Adult Stem Cells (ASCs)

11.5. Europe Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Organoids Market Attractiveness Analysis

11.6.1. By Type

11.6.2. By Application

11.6.3. By Source

11.6.4. By Country/Sub-region

12. Asia Pacific Organoids Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Organoids Market Value Forecast, by Type,2018–2030

12.2.1. Stomach

12.2.2. Intestine

12.2.3. Liver

12.2.4. Pancreas

12.2.5. Lung

12.2.6. Brain

12.2.7. Kidney

12.2.8. Others

12.3. Asia Pacific Organoids Market Value Forecast, by Application, 2018–2030

12.3.1. Developmental Biology

12.3.2. Disease Pathology of Infectious Disease

12.3.3. Regenerative Medicine

12.3.4. Drug Toxicity & Efficacy Testing

12.3.5. Drug Discovery & Personalized Medicine

12.3.6. Others

12.4. Asia Pacific Organoids Market Value Forecast, by Source, 2018–2030

12.4.1. Pluripotent Stem Cells (hIPSCs)

12.4.2. Organ-speci?c Adult Stem Cells (ASCs)

12.5. Asia Pacific Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Organoids Market Attractiveness Analysis

12.6.1. By Type

12.6.2. By Application

12.6.3. By Source

12.6.4. By Country/Sub-region

13. Latin America Organoids Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Organoids Market Value Forecast, by Type,2018–2030

13.2.1. Stomach

13.2.2. Intestine

13.2.3. Liver

13.2.4. Pancreas

13.2.5. Lung

13.2.6. Brain

13.2.7. Kidney

13.2.8. Others

13.3. Latin America Organoids Market Value Forecast, by Application, 2018–2030

13.3.1. Developmental Biology

13.3.2. Disease Pathology of Infectious Disease

13.3.3. Regenerative Medicine

13.3.4. Drug Toxicity & Efficacy Testing

13.3.5. Drug Discovery & Personalized Medicine

13.3.6. Others

13.4. Latin America Organoids Market Value Forecast, by Source, 2018–2030

13.4.1. Pluripotent Stem Cells (hIPSCs)

13.4.2. Organ-speci?c Adult Stem Cells (ASCs)

13.5. Latin America Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Organoids Market Attractiveness Analysis

13.6.1. By Type

13.6.2. By Application

13.6.3. By Source

13.6.4. By Country/Sub-region

14. Middle East & Africa Organoids Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Organoids Market Value Forecast, by Type,2018–2030

14.2.1. Stomach

14.2.2. Intestine

14.2.3. Liver

14.2.4. Pancreas

14.2.5. Lung

14.2.6. Brain

14.2.7. Kidney

14.2.8. Others

14.3. Middle East & Africa Organoids Market Value Forecast, by Application, 2018–2030

14.3.1. Developmental Biology

14.3.2. Disease Pathology of Infectious Disease

14.3.3. Regenerative Medicine

14.3.4. Drug Toxicity & Efficacy Testing

14.3.5. Drug Discovery & Personalized Medicine

14.3.6. Others

14.4. Middle East & Africa Organoids Market Value Forecast, by Source, 2018–2030

14.4.1. Pluripotent Stem Cells (hIPSCs)

14.4.2. Organ-speci?c Adult Stem Cells (ASCs)

14.5. Middle East & Africa Organoids Market Value Forecast, by Country/Sub-region, 2018–2030

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Organoids Market Attractiveness Analysis

14.6.1. By Type

14.6.2. By Application

14.6.3. By Source

14.6.4. By Country/Sub-region

15. Competitive Landscape

15.1. Market Player – Competition Matrix (by tier and size of companies)

15.2. Company Profiles

15.2.1.STEMCELL Technologies, Inc.

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Product Portfolio

15.2.1.3. Strategic Overview

15.2.1.4. SWOT Analysis

15.2.2.Cellesce Ltd

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Product Portfolio

15.2.2.3. Strategic Overview

15.2.2.4. SWOT Analysis

15.2.3. Hubrecht Organoid Technology

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Product Portfolio

15.2.3.3. Strategic Overview

15.2.3.4. SWOT Analysis

15.2.4.Definigen

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Product Portfolio

15.2.4.3. Strategic Overview

15.2.4.4. SWOT Analysis

15.2.5.3Dnamics, Inc.

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Product Portfolio

15.2.5.3. Strategic Overview

15.2.5.4. SWOT Analysis

15.2.6.Organoid Therapeutics

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Product Portfolio

15.2.6.3. Strategic Overview

15.2.6.4. SWOT Analysis

15.2.7. PeproTech, Inc.

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Product Portfolio

15.2.7.3. Strategic Overview

15.2.7.4. SWOT Analysis

15.2.8. Thermo Fisher Scientific

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Financial Overview

15.2.8.3. Product Portfolio

15.2.8.4. Strategic Overview

15.2.8.5. SWOT Analysis

15.2.9.Corning Incorporated (Life Sciences)

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Financial Overview

15.2.9.3. Product Portfolio

15.2.9.4. Strategic Overview

15.2.9.5. SWOT Analysis

15.2.10. Merck KGgA

15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.10.2. Financial Overview

15.2.10.3. Product Portfolio

15.2.10.4. Strategic Overview

15.2.10.5. SWOT Analysis

List of Tables

Table 01: Global Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 02: Global Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 03: Global Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 04: Global Organoids Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America Organoids Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America Organoids Market Value Forecast, by Type, 2018–2030
Table 07: North America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 08: North America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 09: Europe Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 10: Europe Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 11: Europe Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 12: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 13: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 14: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 15: Latin America Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 16: Latin America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 17: Latin America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 18: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 19: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 20: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030

---